Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Empowering mothers to prevent postpartum depression

Official title: The Effect of Stories to Empower Mothers Programme on Postpartum Depression in Primigravid Pregnant Women

Run by Ege University · NCT06787300 · Data updated 2026-11-12

This study is testing a new online program that helps first-time pregnant women use art to boost their mental health and reduce the risk of postpartum depression.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment30 (estimated)
SponsorEge University
Academic / other
Locations1 site (Izmir)
StatusRecruiting
StartedApril 1, 2021
Main results expectedJune 10, 2025
Study endsNovember 2, 2025
Registry record updatedJanuary 22, 2025
Trial IDNCT06787300 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are first-time pregnant women between 24-32 weeks of gestation who have access to the internet and are willing to participate.

Probably not a fit

Patients who are in their first trimester, have psychiatric diagnoses, or face complications during pregnancy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop and evaluate the 'Stories that Empower Mothers' program, designed to assess and enhance the mental health of first-time pregnant women. The program consists of six online sessions, focusing on the therapeutic power of art and psychiatric nursing principles to mitigate the risk of postpartum depression. Participants will be monitored through a quantitative, non-randomized experimental design with intervention and control groups, assessing their psychological resilience and postpartum depression risk. The study will involve pretest, posttest, and follow-up assessments to measure the program's effectiveness.

Why it matters

Potential benefit: If successful, this program could significantly reduce the incidence of postpartum depression among first-time mothers.

How similar studies have gone: Other studies have shown success with similar therapeutic approaches, indicating potential for positive outcomes in mental health interventions for pregnant women.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* First pregnancy,
* Singleton pregnancy,
* Gestational week between 24-32,
* Regular doctor follow-up,
* Scored ≥ 10 on the EDBS,
* Scored \< 17 on the BDI,
* Literate,
* No disability in sensory organs that would prevent communication,
* Owning a smart phone or computer,
* Having internet access,
* Volunteering

Exclusion Criteria:

* Being in the first trimester of pregnancy,

  * Being treated/therapized with any psychiatric diagnosis,
  * Having a risky pregnancy,
  * Being at risk of premature birth and developing it,
  * Having any complications related to pregnancy (gestational diabetes, hypertension, bleeding, etc.),
  * The baby is not healthy,
  * Developing complications during and after birth,
  * The baby needs intensive care after birth,
  * Having a baby lost,
  * Having a premature birth (\<37 weeks),
  * The mother has experienced serious daily life difficulties (disaster, loss, etc.),
  * Not attending three or more of the six sessions

Where it's running

  • Ege University
    Izmir, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.